American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Devlin
    Devlin
  3. Levine
    Levine
  4. Perales
    Perales
  5. Abdel-Wahab
    Abdel-Wahab
  6. Landau
    Landau
  7. Shah
    Shah
  8. Famulare
    Famulare
  9. Rampal
    Rampal
  10. Stein
    Stein

Groups

  1. Center for Hematologic Malignancies (198)
  2. Department of Medicine (189)
  3. Hematologic Malignancies, Division of (185)
  4. Adult Leukemia (87)
  5. GSK Faculty (76)
  6. Executive Committee, Center for Hematologic Malignancies (57)
  7. Sloan Kettering Institute Postdocs (49)
  8. Bone Marrow Transplant (45)
  9. Survivorship Research (40)
  10. Hematologic Malignancies Research (39)
Search Within
  1. "2018"
  2. "Meeting abstract"
Formats
  1. Meeting Abstract (220)
Groups
  1. Center for Hematologic Malignancies (198)
  2. Department of Medicine (189)
  3. Hematologic Malignancies, Division of (185)
  4. Adult Leukemia (87)
  5. GSK Faculty (76)
  6. Executive Committee, Center for Hematologic Malignancies (57)

More Groups

People
  1. Sergio Giralt (29)
  2. Martin Tallman (28)
  3. Sean Devlin (25)
  4. Ross Levine (21)
  5. Anthony Mato (18)
  6. Carl Landgren (17)

More People

Years
  1. 2018 (220)
Publications
  1. Blood (220)

Results (220)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients with previously untreated non-germinal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Younes, A.; Sehn, L. H.; Johnson, P.; Zinzani, P. L.; Hong, X.; Zhu, J.; Samoilova, O.; Suh, C.; Matsumura, I.; Lopez-Hernandez, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The role of microRNAs in the pathogenesis of Erdheim-Chester disease and their potential use as biomarkers for diagnosis and prognosis of the disease
    Meeting Abstract

    Weissman, R.; Pilar, N.; Durham, B. H.; Ki, M.; Mazor, R. D.; Abdel-Wahab, O. I.; Shomron, N.; Shpilberg, O.; Diamond, E. L.; Rokah, O.
    Blood (2018)

    Fulltext@MSK | Save
  • Mutations in the RNA splicing factor SF3B1 promote transformation through MYC stabilization
    Meeting Abstract

    Yoshimi, A.; Liu, Z.; Wang, J.; Cho, H.; Lee, S. C.; Ki, M.; Bitner, L. E.; Chu, T.; Mato, A. R.; Ruvolo, P. P.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel iPSC model reveals a role for RUNX1 in the maintenance of AML leukemia stem cells
    Meeting Abstract

    Wesely, J.; Kotini, A. G.; Georgomanoli, M.; Luo, H.; Yuan, H.; Izzo, F.; Landau, D. A.; Leslie, C.; Kharas, M. G.; Papapetrou, E. P.
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Mice with a unique mutator phenotype allow detection of lymphoid leukemia tumor suppressor genes
    Meeting Abstract

    Yin, M.; Baslan, T.; Freeland, A.; Matsukawa, T.; Pruitt, S. C.; Aplan, P. D.
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Tripodi, J.; Najfeld, V.; Petersen, B.; Rampal, R. K.; Farnoud, N.; Famulare, C.; Mascarenhas, J.; Hoffman, R.
    Blood (2018)

    Fulltext@MSK | Save
  • Cardiovascular mortality among CML patients in the pre-TKI and TKI eras: A SEER analysis 1992-2004
    Meeting Abstract

    Wang, Q.; Zhang, Y.; Yue, B.; Zhang, Y.; Jiang, C.; Perimbeti, S.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Front-line ibrutinib treatment is associated with longer time to next treatment, net total cost reduction, and lower healthcare resource utilization compared to chemoimmunotherapy in patients with chronic lymphocytic leukemia
    Meeting Abstract

    Wang, S.; Emond, B.; Romdhani, H.; Lefebvre, P.; Sundaram, M.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save